154 related articles for article (PubMed ID: 20202112)
1. Classification of invasive fungal disease in patients with acute myeloid leukaemia.
Rieger CT; Huppmann S; Peterson L; Rieger H; Ostermann H
Mycoses; 2011 Jul; 54(4):e92-8. PubMed ID: 20202112
[TBL] [Abstract][Full Text] [Related]
2. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis.
Tsitsikas DA; Morin A; Araf S; Murtagh B; Johnson G; Vinnicombe S; Ellis S; Suaris T; Wilks M; Doffman S; Agrawal SG
Med Mycol; 2012 Jul; 50(5):538-42. PubMed ID: 22074309
[TBL] [Abstract][Full Text] [Related]
3. Organising pneumonia mimicking invasive fungal disease in patients with leukaemia.
Forghieri F; Potenza L; Morselli M; Maccaferri M; Pedrazzi L; Barozzi P; Vallerini D; Riva G; Zanetti E; Quadrelli C; Rossi G; Rivasi F; Messino' M; Rumpianesi F; Grottola A; Venturelli C; Pecorari M; Codeluppi M; Torelli G; Luppi M
Eur J Haematol; 2010 Jul; 85(1):76-82. PubMed ID: 20148942
[TBL] [Abstract][Full Text] [Related]
4. Applicability of the EORTC/MSG criteria for IFD in clinical practice.
Rieger H; Lustig D; Barlow S; Ostermann H; Fiegl M; Peterson L; Rieger CT
Ann Hematol; 2015 May; 94(5):847-55. PubMed ID: 25544029
[TBL] [Abstract][Full Text] [Related]
5. [Invasive fungal disease in hemato-oncological and hematopoietic stem cell transplantation patients from Hospital Clinico Universidad Católica, Santiago-Chile using revised EORTC/MSG diagnostic criteria].
Rabagliati B R; Fuentes L G; Guzmán D AM; Orellana U E; Oporto C J; Aedo C I; Garrido S M; Nervi N B
Rev Chilena Infectol; 2009 Jun; 26(3):212-9. PubMed ID: 19621153
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
7. Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals.
Rieger CT; Cornely OA; Hoppe-Tichy T; Kiehl M; Knoth H; Thalheimer M; Schuler U; Ullmann AJ; Ehlken B; Ostermann H
Mycoses; 2012 Nov; 55(6):514-20. PubMed ID: 22471310
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.
Nucci M; Garnica M; Gloria AB; Lehugeur DS; Dias VC; Palma LC; Cappellano P; Fertrin KY; Carlesse F; Simões B; Bergamasco MD; Cunha CA; Seber A; Ribeiro MP; Queiroz-Telles F; Lee ML; Chauffaille ML; Silla L; de Souza CA; Colombo AL
Clin Microbiol Infect; 2013 Aug; 19(8):745-51. PubMed ID: 23009319
[TBL] [Abstract][Full Text] [Related]
9. Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation.
Herbrecht R; Caillot D; Cordonnier C; Auvrignon A; Thiébaut A; Brethon B; Michallet M; Mahlaoui N; Bertrand Y; Preziosi P; Ruiz F; Gorin NC; Gangneux JP
J Antimicrob Chemother; 2012 Nov; 67(11):2731-8. PubMed ID: 22850692
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Borlenghi E; Cattaneo C; Capucci MA; Pan A; Quaresmini G; Franco F; Grazioli L; Carosi GP; Rossi G
Ann Hematol; 2007 Mar; 86(3):205-10. PubMed ID: 17119965
[TBL] [Abstract][Full Text] [Related]
11. Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.
Cornely OA; Maertens J; Bresnik M; Ebrahimi R; Dellow E; Herbrecht R; Donnelly JP
Mycoses; 2011 Sep; 54(5):e449-55. PubMed ID: 21039936
[TBL] [Abstract][Full Text] [Related]
12. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
Hoenigl M; Strenger V; Buzina W; Valentin T; Koidl C; Wölfler A; Seeber K; Valentin A; Strohmeier AT; Zollner-Schwetz I; Raggam RB; Urban C; Lass-Flörl C; Linkesch W; Krause R
J Antimicrob Chemother; 2012 Aug; 67(8):2029-33. PubMed ID: 22566591
[TBL] [Abstract][Full Text] [Related]
13. Pre-emptive diagnosis and treatment of fungal infections--evaluation of a single-centre policy.
Schneider T; Halter J; Heim D; Passweg J; Stern M; Tichelli A; Weisser M; Gerull S
Clin Microbiol Infect; 2012 Feb; 18(2):189-94. PubMed ID: 21729194
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive diagnostic approach using galactomannan, targeted β-d-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients.
Ceesay MM; Desai SR; Berry L; Cleverley J; Kibbler CC; Pomplun S; Nicholson AG; Douiri A; Wade J; Smith M; Mufti GJ; Pagliuca A
Br J Haematol; 2015 Jan; 168(2):219-29. PubMed ID: 25179933
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
Hammond SP; Marty FM; Bryar JM; DeAngelo DJ; Baden LR
Am J Hematol; 2010 Sep; 85(9):695-9. PubMed ID: 20652970
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with posaconazole prophylaxis--a retrospective analysis in a haematological unit.
Hahn J; Stifel F; Reichle A; Holler E; Andreesen R
Mycoses; 2011 Jan; 54 Suppl 1():12-6. PubMed ID: 21126267
[TBL] [Abstract][Full Text] [Related]
17. Galactomannan in bronchoalveolar lavage for diagnosing invasive fungal disease.
Affolter K; Tamm M; Jahn K; Halter J; Passweg J; Hirsch HH; Stolz D
Am J Respir Crit Care Med; 2014 Aug; 190(3):309-17. PubMed ID: 25007380
[TBL] [Abstract][Full Text] [Related]
18. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of a panfungal polymerase chain reaction assay for invasive fungal diseases in patients with haematologic disorders.
Sugawara Y; Nakase K; Nakamura A; Ohishi K; Sugimoto Y; Fujieda A; Monma F; Suzuki K; Masuya M; Matsushima Y; Wada H; Nobori T; Katayama N
Eur J Haematol; 2013 Apr; 90(4):331-9. PubMed ID: 23360173
[TBL] [Abstract][Full Text] [Related]
20. New category of probable invasive pulmonary aspergillosis in haematological patients.
Girmenia C; Guerrisi P; Frustaci AM; Fama A; Finolezzi E; Perrone S; Gentile G; Collerone F; Brocchieri S; Guerrisi V
Clin Microbiol Infect; 2012 Oct; 18(10):990-6. PubMed ID: 21999366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
